Annual Congress Copenhagen 2005

Saturday, 17.09.2005
Sunday, 18.09.2005
Monday, 17.09.2005
Tuesday, 20.09.2005
Wednesday, 21.09.2005

Citations should be made in the following way: Authors. Title. Eur Respir J 2005; 26: Suppl. 49, abstract number.

Material from 2005:

4063 Abstracts
739 Slide presentations
213 Webcasts
93 Handouts

Material from 2005: Show

Therapeutic options for COPD: present and future

Oral Presentation
Chairs: C. Page (London, United Kingdom), M. Cazzola (Naples, Italy)

Download all media

GM-CSF is a key pathogenic mediator in experimental COPD R. Vlahos, S. Bozinovski, L. B. Irving, J. A. Hamilton, G. P. Anderson (Parkville, Australia)
Employing flow cytometric assays of human whole blood neutrophil and monocyte CD11b upregulation and shape change to assess a chemokine receptor (CXCR2) antagonist G. C. Nicholson, D. C. Carpenter, R. M. Tal-Singer, R. C. Tennant, P. J. Barnes, T. T. Hansel (London, United Kingdom; Philadelphia, United States Of America)
Expression of adenosine receptors in the peripheral lung from COPD patients K. Varani, G. Caramori, P. Casolari, C. Pancaldi, F. Vincenzi, I. M. Adcock, K. F. Chung, P. J. Barnes, G. Cavallesco, G. Azzena, P. A. Borea, A. Papi (Ferrara, Italy; London, United Kingdom)
N-acetylcysteine reduces 8-isoprostane levels in exhaled breath condensate and serum of COPD patients E. Bucchioni, T. Cappelletti, G. Pozzoli, S. Galbiati, B. Dallari, L. Allegra (Milan, Italy)
Corticosteroid sensitivity in patients with chronic obstructive pulmonary disease is restored by theophylline Y. To, S. Kharitonov, I. M. Adcock, P. J. Barnes, K. Ito (London, United Kingdom)
Cigarette smoke-induced IL-8 production by human monocyte-derived macrophages: synergistic inhibition by fluticasone and salmeterol H. Sarir, E. Mortaz, F. Nijkamp, G. Folkerts (Utrecht, Netherlands)
Comparison of a combination of tiotropium and formoterol to salmeterol and fluticasone in moderate COPD K. F. Rabe, W. Timmer, A. Sagriotis, K. Viel (Leiden, Netherlands; Biberach, Germany)
Clinical effects of adding fluticasone propionate/salmeterol (FSC) and tiotropium (TIO) in severe-to-very severe COPD M. D‘Amato, F. Andò, P. Santus, P. Ruggeri, F. Di Marco, M. Cazzola (Naples, Messina, Milan, Italy)